Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:10 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 841–864 of 4,843 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Depressed Clear all

Conditions: Anxiety, Depression, Sleep Quality, Cognitive Impairment
Interventions: Low Dose MMFS-205-SR, High Dose MMFS-205-SR, Placebo; Dietary Supplement
Lead sponsor: Neurocentria, Inc.; Industry
Eligibility: 60 Years to 85 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Springfield, Missouri

Conditions: Major Depressive Disorder
Interventions: Pregnenolone 500 mg, Pregnenolone 800 mg, Placebo; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Depression
Interventions: Education; Behavioral
Lead sponsor: RAND; Other
Eligibility: 13 Years to 17 Years
Enrollment: 368 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 8
States / cities: Los Angeles, California • San Fernando, California • Washington D.C., District of Columbia + 4 more

Conditions: Cortical Spreading Depolarization, Cortical Spreading Depression, Subarachoid Hemorrhage, Traumatic Brain Injury
Interventions: ketamine; Drug
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years to 90 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: COVID-19, Pregnancy Complications, Mental Health Wellness 1, Anxiety, Depression, Ptsd, Coronavirus
Interventions: This is an online survey with no intervention.; Other
Lead sponsor: Pregistry; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 6,894 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Depression, Anxiety
Interventions: BCBT, SMHC referral; Behavioral
Lead sponsor: Robert Wood Johnson Foundation; Other
Eligibility: 7 Years to 17 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Depression
Interventions: Modified Interpersonal Therapy, Attention control/usual care; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 15 Years and older · Female only
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 6
States / cities: Syracuse, New York • Asheville, North Carolina • Chapel Hill, North Carolina + 2 more

Conditions: Stroke Sequelae, Cognitive Impairment, Depression
Interventions: Integrative tele-rehalitation of chronic stroke survivors using custom therapeutic games; Device
Lead sponsor: Grigore Burdea; Industry
Eligibility: 48 Years to 80 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Bipolar Depression
Interventions: lurasidone + (lithium or divalproex), Placebo + (lithium or divalproex); Drug
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 348 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 27
States / cities: Little Rock, Arkansas • Anaheim, California • Chino, California + 21 more

Conditions: Maternal Behavior, Depression
Interventions: Well Child Visits; Behavioral
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 13 Years to 67 Years
Enrollment: 1,625 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Major Depressive Disorder
Interventions: ALTO-300 oral (PO) tablet; Drug
Lead sponsor: Alto Neuroscience; Industry
Eligibility: 18 Years to 74 Years
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 11
States / cities: Culver City, California • Sacramento, California • Santee, California + 8 more

Conditions: Depression, Depressive Disorder, Depressive Symptoms, Depressive Disorder, Major, Depressive Episode, Depression Severe
Interventions: TNX-601 ER, Placebo; Drug
Lead sponsor: Tonix Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 27
States / cities: Little Rock, Arkansas • Bellflower, California • Glendale, California + 24 more

Conditions: Depression
Interventions: Not listed
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 8 Years to 21 Years
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Depression, Anxiety
Interventions: Lumen Treatment; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Depressive Symptoms
Interventions: Group-based therapy; Behavioral
Lead sponsor: Oregon Research Institute; Other
Eligibility: 18 Years to 28 Years
Enrollment: 91 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Premenstrual Syndrome, PMS, Healthy, Depression
Interventions: Dutasteride, Placebo oral capsule; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 30 Years to 50 Years · Female only
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2014
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Major Depressive Disorder
Interventions: Behavioral Activation, Exercise Intervention, Stretching Intervention; Behavioral
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 18 Years to 65 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Anxiety, Depression, Caregiver Burnout, Anxiety Generalized
Interventions: Remember Stuff: A Dyadic-focused Technology to Support Persons with Alzheimer's Disease in the Community; Other
Lead sponsor: Indiana University; Other
Eligibility: 21 Years to 95 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Maternal-Fetal Relations, Paternal Behavior, Maternal Behavior
Interventions: 3D printed model, Placebo; Other
Lead sponsor: Creighton University; Other
Eligibility: 19 Years to 45 Years
Enrollment: 288 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Stress Disorders, Post-Traumatic, Anxiety, Depression
Interventions: Trauma-focused cognitive behavioral therapy (TF-CBT), Child-centered supportive therapy (CCT); Behavioral
Lead sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute); Other
Eligibility: 7 Years to 14 Years
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2015
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Depression - Major Depressive Disorder, Psychological Distress, Depression / Major Depressive Disorder
Interventions: Non-deceptive placebo (NDP); Other
Lead sponsor: Miami University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 330 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Oxford, Ohio

Conditions: Stress, Caregiver Burden, Anxiety, Depressive Symptoms
Interventions: Self-Compassion Based Resilient Caregiving Course; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Depression
Interventions: TIP; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 65 Years and older
Enrollment: 231 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 2
States / cities: Ann Arbor, Michigan • New York, New York

Conditions: Problem Behaviors, Attention Deficit Hyperactivity Disorder, Depression
Interventions: Attachment and Biobehavioral Catch-up, Developmental Education for Families; Behavioral
Lead sponsor: University of Delaware; Other
Eligibility: 20 Months to 36 Months
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2016
U.S. locations: 1
States / cities: Newark, Delaware

Search by objective public record fields.

Comparison of MMFS Dosages in Older Adults

Development of Pregnenolone as a Treatment for Depression

Teen Depression Awareness Project (TDAP)

Spreading Depolarization and Ketamine Suppression

Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic

Clinical and Cost Effectiveness of Brief Cognitive-Behavioral Therapy (CBT) for Pediatric Internalizing Disorders

Reducing Symptoms of Depression in Low-Income Mothers

Remote Bimanual Virtual Rehabilitation Post CVD

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)

Interconception Care at the University of Mississippi Medical Center

ALTO-300 in Depression

Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)

Ability to Cope With Type 1 Diabetes

Study of a PST-Trained Voice-Enabled Artificial Intelligence Counselor (SPEAC) for Adults With Emotional Distress (Phase 1)

Pilot Study Comparing Two Versions of Group Cognitive-behavioral Indicated Prevention Programs

Dutasteride to Treat Women With Menstrually Related Mood Disorders

Efficacy of Adjunctive Exercise for the Behavioral Treatment of Major Depression

Remember Stuff: A Dyadic-focused Technology to Support Persons With Alzheimer's Disease in the Community

3D Maternal Fetal Bonding

Treating Post Traumatic Stress Disorder in Children Exposed to Domestic Violence

Testing a Non-Deceptive Placebo Intervention for Subclinical Depressive Symptoms

Self-Compassion to Enhance the Well-Being of Caregivers of Children With Physical Disabilities

Personalized Antidepressant Adherence Strategies For Depressed Elders

Mental Health Services for Foster and Adopted Children